Meghan Morris, PhD

Photo of Meghan Morris, PhD

Email Meghan
(415) 476-5822

550 16th. Street
San Francisco, CA 94158

Visit CTSI Profile

  • Assistant Professor, UCSF School of Medicine

Biography

I am a mixed-method epidemiologist with graduate training in infectious disease and social epidemiology. I am interested understanding the biological, contextual, and policy aspects that place injection drug users at greater risk for HIV, hepatitis C infection and other negative health outcomes.

Displaying 1 - 29 of 29

  1. Morris MD, Brown B, Allen SA. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health. Int J Prison Health. 2017 Sep 11; 13(3-4):192-199. View on Pubmed
  2. Morris MD, Neilands TB, Andrew E, Maher L, Page KA, Hahn JA. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships. Int J Drug Policy. 2017 Oct; 48:54-62. View on Pubmed
  3. Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Clin Infect Dis. 2017 Apr 01; 64(7):860-869. View on Pubmed
  4. Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA. Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection. Infect Genet Evol. 2017 Apr; 49:88-96. View on Pubmed
  5. Rodrigo C, Eltahla AA, Bull RA, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Estes C, Razavi H, Lloyd AR, Luciani F. Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia. J Infect Dis. 2016 Nov 01; 214(9):1383-1389. View on Pubmed
  6. Baer RJ, Rogers EE, Partridge JC, Anderson JG, Morris M, Kuppermann M, Franck LS, Rand L, Jelliffe-Pawlowski LL. Population-based risks of mortality and preterm morbidity by gestational age and birth weight. J Perinatol. 2016 Nov; 36(11):1008-1013. View on Pubmed
  7. Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH. Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis. 2016 Jan; 3(1):ofw024. View on Pubmed
  8. Morris MD, Bates A, Andrew E, Hahn J, Page K, Maher L. More than just someone to inject drugs with: Injecting within primary injection partnerships. Drug Alcohol Depend. 2015 Nov 01; 156:275-81. View on Pubmed
  9. Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, Matthews G, Rice TM, Morris MD, McGovern BH, Kim AY, Bruneau J, Lloyd AR, Page K, Manns MP, Hellard ME, Dore GJ. Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort. J Viral Hepat. 2015 Dec; 22(12):1020-32. View on Pubmed
  10. Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M. Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study. J Infect Dis. 2015 Nov 01; 212(9):1407-19. View on Pubmed
  11. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J. Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. PLoS One. 2015; 10(4):e0122232. View on Pubmed
  12. Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J. A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs. J Epidemiol Community Health. 2015 Aug; 69(8):745-52. View on Pubmed
  13. Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA. PLoS One. 2014; 9(10):e109282. View on Pubmed
  14. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J. Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study. J Clin Virol. 2014 Nov; 61(3):430-4. View on Pubmed
  15. Evans JL, Morris MD, Yu M, Page K, Hahn JA. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA. Drug Alcohol Depend. 2014 Sep 01; 142:239-44. View on Pubmed
  16. Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, Lum PJ, Page K. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014 May 29; 4(5):e004988. View on Pubmed
  17. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan; 59(1):109-20. View on Pubmed
  18. Page K, Morris MD, Hahn JA, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S32-8. View on Pubmed
  19. Briceño A, Morris MD, Evans J, Raymond HF, Page K. Characteristics and health service utilization in two samples of young injection drug users recruited using direct and referral methods in San Francisco, California. J Alcohol Drug Depend. 2013 Aug; 1(5). View on Pubmed
  20. Morris MD, Quezada L, Bhat P, Moser K, Smith J, Perez H, Laniado-Laborin R, Estrada-Guzman J, Rodwell TC. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective. Int J Tuberc Lung Dis. 2013 Jul; 17(7):954-60. View on Pubmed
  21. Briceno A, Morris M.D., Evans J,Fisher R.H., and Page K,. Characteristics and Health Service Utilization in Two Samples of Young Injection Drug Users Recruited Using Direct and Referral Methods in San Francisco, California. Alcoholism & Drug Dependence. 2013; 1(5).
  22. Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K. Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol. 2013 Dec; 42(6):1649-59.
  23. Morris MD, Lemus H, Wagner KD, Martinez G, Lozada R, Gómez RM, Strathdee SA. Factors associated with pathways toward concurrent sex work and injection drug use among female sex workers who inject drugs in northern Mexico. Addiction. 2013 Jan; 108(1):161-70.
  24. Stockman JK, Morris MD, Martinez G, Lozada R, Patterson TL, Ulibarri MD, Vera A, Strathdee SA. Prevalence and correlates of female condom use and interest among injection drug-using female sex workers in two Mexico-US border cities. AIDS Behav. 2012 Oct; 16(7):1877-86.
  25. Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis. 2012 May; 12(5):408-14.
  26. Morris MD, Brouwer KC, Lozada RM, Gallardo M, Vera A, Strathdee SA. "Injection first": a unique group of injection drug users in Tijuana, Mexico. Am J Addict. 2012 Jan-Feb; 21(1):23-30.
  27. Morris MD, Case P, Robertson AM, Lozada R, Vera A, Clapp JD, Medina-Mora ME, Strathdee SA. Prevalence and correlates of 'agua celeste' use among female sex workers who inject drugs in Ciudad Juarez, Mexico. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):219-25.
  28. Rondinelli AJ, Morris MD, Rodwell TC, Moser KS, Paida P, Popper ST, Brouwer KC. Under- and over-nutrition among refugees in San Diego County, California. J Immigr Minor Health. 2011 Feb; 13(1):161-8.
  29. Morris MD, Popper ST, Rodwell TC, Brodine SK, Brouwer KC. Healthcare barriers of refugees post-resettlement. J Community Health. 2009 Dec; 34(6):529-38.